Following intranasal inoculation of wild-type BHV-5 in rabbits, we studied
the sequential transneuronal passage of the virus in the CNS by immunocytoc
hem istry, histopathology, and virus isolation. At 4 and 6 days postinfecti
on (d.p.i,), rabbits had no or mild neurological signs, and virus was isola
ted only from the olfactory bulbs. At 8 and 9 d.p.i., infected rabbits had
severe neurological signs, and virus could be isolated from multiple region
s of the brain segments, In these rabbits, high titers of virus were consis
tently present in the anterior and posterior cortices, including frontal, p
iriform/entorhinal, temporal, parietal, and occipital cortices, the hippoca
mpus and the amygdala. Virus was isolated occasionally from the midbrain/di
encephalon and pons/medulla. Virus was not isolated from the cerebellum and
trigeminal ganglion of rabbits examined from 2-12 d.p.i. Immunocytochemist
ry revealed virus-specific antigens at 4 d.p.i. within the glomerular layer
, external plexiform layer, and mitral cell layer of the main olfactory bul
b. At 6 d.p.i., virus-specific antigens were also present within the inner
granular layer of the main olfactory bulb. At 8 and 9 d.p.i., widespread BH
V-5-specific staining occurred in the areas of the brain connected to the m
ain olfactory bulb, including the frontal/cingulate cortex, anterior olfact
ory nucleus, lateral olfactory tubercle, piriform/entorhinal cortex, hippoc
ampus, amygdala, dorsal raphe, and locus coeruleus. In the trigeminal gangl
ion, specific staining tvas detected within a few neurons at 2, 4, 6, 8 d.p
.i. However, further spread of the virus along the trigeminal pathway was n
ot evident. These data indicate that BHV-5 replicates and spreads preferent
ially in the olfactory pathway following intranasal instillation and that t
his viral spread correlated with the severity of neurological symptoms and
histopathological lesions.